Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

A clinical study into weight loss drugs for pets just launched, with results from the trial expected by next summer.

Vets are exploring new medicines for overweight cats. These drugs mimic hormones that reduce appetite and improve glucose ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study for cats. MEOW-1, as the study is called, will look to use OKV-119, a ...

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

“Caloric restriction, or fasting, is one of the most well-established interventions for extending lifespan and improving ...

The world's first GLP-1 weight-loss treatment for pets has begun with successful cat dosing. The six-month implant could ...

The device, OKV-119, is a GLP-1 implant, or a small device inserted under the skin that can deliver doses of medication for up to six months.

Around 70% of Americans are obese or overweight. And their cats aren’t too far off. According to the Association for Pet ...

The first of its kind medical trial will see cats take a specially-designed weight loss drug designed to help them lose ...

A new weight-loss treatment for cats, inspired by the popular human drug Ozempic, is currently being tested by veterinarians. OKAVA Pharmaceuticals has announced that its first clinical trial for ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.